ROBINS CHAD M Insider Trading
Get the latest insider transactions of ROBINS CHAD M. ROBINS CHAD M is CEO and Chairman in Adaptive Biotechnologies Corp ($ADPT). Discover the current value of ROBINS CHAD M shares.
Address: C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1551 EASTLAKE AVE E STE 200 SEATTLE 98102WA
ROBINS CHAD M is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | CEO and Chairman | 1,761,861 |
Insider Trading Transactions of ROBINS CHAD M
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Apr 08 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 41.08 | 1,600 | 65,728 | 1,761,861 |
| Apr 08 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 42.48 | 2,200 | 93,456 | 1,759,661 |
| Apr 08 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 43.08 | 1,200 | 51,696 | 1,758,461 |
| Apr 08 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 40.61 | 3,900 | 158,379 | 1,754,561 |
| Apr 08 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 41.45 | 1,100 | 45,595 | 1,753,461 |
| Apr 08 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 42.04 | 2,943 | 123,724 | 1,750,518 |
| Apr 08 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 43.00 | 1,957 | 84,151 | 1,748,561 |
| Apr 08 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 43.78 | 100 | 4,378 | 1,748,461 |
| Mar 19 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 43.22 | 1,901 | 82,161 | 1,776,560 |
| Mar 19 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 44.03 | 1,295 | 57,019 | 1,775,265 |
| Mar 19 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 45.25 | 1,804 | 81,631 | 1,773,461 |
| Mar 19 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 41.90 | 1,926 | 80,699 | 1,771,535 |
| Mar 19 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 42.81 | 2,604 | 111,477 | 1,768,931 |
| Mar 19 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 43.78 | 470 | 20,577 | 1,768,461 |
| Mar 19 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 41.96 | 4,900 | 205,604 | 1,763,561 |
| Mar 19 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 42.48 | 100 | 4,248 | 1,763,461 |
| Mar 08 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.00 | 68,681 | 0 | 1,778,461 |
| Mar 08 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 43.68 | 171,703 | 7,499,987 | 171,703 |
| Feb 10 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 61.40 | 7,314 | 449,080 | 1,732,466 |
| Feb 10 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 62.20 | 2,686 | 167,069 | 1,729,780 |
| Feb 10 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 62.07 | 5,840 | 362,489 | 1,723,940 |
| Feb 10 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 63.23 | 4,160 | 263,037 | 1,719,780 |
| Feb 10 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 61.51 | 795 | 48,900 | 1,718,985 |
| Feb 10 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 62.56 | 6,801 | 425,471 | 1,712,184 |
| Feb 10 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 63.25 | 1,204 | 76,153 | 1,710,980 |
| Feb 10 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 64.27 | 1,200 | 77,124 | 1,709,780 |
| Jan 28 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 62.51 | 3,850 | 240,664 | 1,765,930 |
| Jan 28 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 63.63 | 2,524 | 160,602 | 1,763,406 |
| Jan 28 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 64.52 | 3,526 | 227,498 | 1,759,880 |
| Jan 28 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 65.23 | 100 | 6,523 | 1,759,780 |
| Jan 28 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 54.63 | 1,879 | 102,650 | 1,757,901 |
| Jan 28 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 56.26 | 1,000 | 56,260 | 1,756,901 |
| Jan 28 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 57.71 | 2,000 | 115,420 | 1,754,901 |
| Jan 28 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 58.79 | 3,246 | 190,832 | 1,751,655 |
| Jan 28 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 59.72 | 1,875 | 111,975 | 1,749,780 |
| Jan 28 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 55.01 | 600 | 33,006 | 1,749,180 |
| Jan 28 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 55.94 | 2,800 | 156,632 | 1,746,380 |
| Jan 28 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 57.32 | 4,300 | 246,476 | 1,742,080 |
| Jan 28 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 57.83 | 2,300 | 133,009 | 1,739,780 |
| Jan 21 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 70.42 | 8,300 | 584,486 | 1,769,880 |
| Jan 21 2021 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 71.14 | 100 | 7,114 | 1,769,780 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,250 | 5,363 | 1,794,430 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 60.71 | 13,542 | 822,135 | 1,780,888 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 61.48 | 1,108 | 68,120 | 1,779,780 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 62.60 | 1,500 | 93,900 | 1,778,280 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,250 | 5,363 | 1,794,430 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 63.41 | 100 | 6,341 | 1,778,180 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 60.71 | 13,542 | 822,135 | 1,780,888 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,790 | 5,541 | 1,794,970 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 61.48 | 1,108 | 68,120 | 1,779,780 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 58.87 | 8,256 | 486,031 | 1,786,714 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 62.60 | 1,500 | 93,900 | 1,778,280 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 59.42 | 6,834 | 406,076 | 1,779,880 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 63.41 | 100 | 6,341 | 1,778,180 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 60.73 | 1,700 | 103,241 | 1,778,180 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,790 | 5,541 | 1,794,970 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,520 | 5,452 | 1,794,700 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 58.87 | 8,256 | 486,031 | 1,786,714 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 59.20 | 7,651 | 452,939 | 1,787,049 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 59.42 | 6,834 | 406,076 | 1,779,880 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 59.65 | 8,869 | 529,036 | 1,778,180 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 60.73 | 1,700 | 103,241 | 1,778,180 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,250 | 5,363 | 33,310 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,520 | 5,452 | 1,794,700 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,790 | 5,541 | 16,520 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 59.20 | 7,651 | 452,939 | 1,787,049 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,520 | 5,452 | 0 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 59.65 | 8,869 | 529,036 | 1,778,180 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,250 | 5,363 | 33,310 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,790 | 5,541 | 16,520 |
| Dec 30 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,520 | 5,452 | 0 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 45.84 | 11,047 | 506,394 | 1,783,813 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 46.68 | 5,633 | 262,948 | 1,778,180 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 46.68 | 1,200 | 56,016 | 1,793,660 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 47.64 | 2,000 | 95,280 | 1,791,660 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 48.52 | 13,480 | 654,050 | 1,778,180 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 45.84 | 11,047 | 506,394 | 1,783,813 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 46.68 | 5,633 | 262,948 | 1,778,180 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 45.60 | 7,647 | 348,703 | 1,787,213 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 46.69 | 3,773 | 176,161 | 1,783,440 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 46.68 | 1,200 | 56,016 | 1,793,660 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 47.75 | 4,360 | 208,190 | 1,779,080 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 47.64 | 2,000 | 95,280 | 1,791,660 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 48.54 | 900 | 43,686 | 1,778,180 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 48.52 | 13,480 | 654,050 | 1,778,180 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 82,920 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 66,240 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 45.60 | 7,647 | 348,703 | 1,787,213 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 49,560 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 46.69 | 3,773 | 176,161 | 1,783,440 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 47.75 | 4,360 | 208,190 | 1,779,080 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 48.54 | 900 | 43,686 | 1,778,180 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 82,920 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 66,240 |
| Nov 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 49,560 |
| Oct 08 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 18,280 | 6,032 | 1,796,460 |
| Oct 08 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 48.99 | 10,178 | 498,620 | 1,786,282 |
| Oct 08 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 49.83 | 8,102 | 403,723 | 1,778,180 |
| Oct 08 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 50,000 | 16,500 | 1,828,180 |
| Oct 08 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 49.40 | 1,200 | 59,280 | 1,826,980 |
| Oct 08 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 50.20 | 48,800 | 2,449,760 | 1,778,180 |
| Oct 08 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 24,260 | 8,006 | 1,802,440 |
| Oct 08 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 50.56 | 22,860 | 1,155,802 | 1,779,580 |
| Oct 08 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 51.37 | 1,400 | 71,918 | 1,778,180 |
| Oct 08 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 18,280 | 6,032 | 173,860 |
| Oct 08 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 50,000 | 16,500 | 123,860 |
| Oct 08 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 24,260 | 8,006 | 99,600 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 45.47 | 6,180 | 281,005 | 1,788,680 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 46.45 | 5,000 | 232,250 | 1,738,680 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 47.46 | 5,100 | 242,046 | 1,778,580 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 48.26 | 400 | 19,304 | 1,778,180 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 44.48 | 2,600 | 115,648 | 1,792,260 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 45.26 | 14,080 | 637,261 | 1,778,180 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 45.28 | 8,100 | 366,768 | 1,786,760 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 45.47 | 6,180 | 281,005 | 1,788,680 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 46.13 | 8,580 | 395,795 | 1,778,180 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 46.45 | 5,000 | 232,250 | 1,738,680 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 228,000 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 47.46 | 5,100 | 242,046 | 1,778,580 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 211,320 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 48.26 | 400 | 19,304 | 1,778,180 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 194,640 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 44.48 | 2,600 | 115,648 | 1,792,260 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 45.26 | 14,080 | 637,261 | 1,778,180 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 45.28 | 8,100 | 366,768 | 1,786,760 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 46.13 | 8,580 | 395,795 | 1,778,180 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 228,000 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 211,320 |
| Sep 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 194,640 |
| Aug 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Aug 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 37.63 | 16,680 | 627,668 | 1,778,180 |
| Aug 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Aug 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 36.51 | 4,937 | 180,250 | 1,789,923 |
| Aug 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 37.40 | 9,743 | 364,388 | 1,780,180 |
| Aug 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 37.96 | 2,000 | 75,920 | 1,778,180 |
| Aug 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Aug 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 36.80 | 901 | 33,157 | 1,793,959 |
| Aug 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 37.50 | 6,774 | 254,025 | 1,787,185 |
| Aug 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 38.43 | 9,005 | 346,062 | 1,778,180 |
| Aug 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 278,040 |
| Aug 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 261,360 |
| Aug 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 244,680 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 20,668 | 6,820 | 1,798,848 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 20,668 | 6,820 | 1,798,848 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 38.14 | 20,668 | 788,278 | 1,778,180 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 38.14 | 20,668 | 788,278 | 1,778,180 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 37.48 | 6,796 | 254,714 | 1,788,064 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 37.48 | 6,796 | 254,714 | 1,788,064 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 37.96 | 9,884 | 375,197 | 1,778,180 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 37.96 | 9,884 | 375,197 | 1,778,180 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 37.19 | 15,480 | 575,701 | 1,779,380 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 37.19 | 15,480 | 575,701 | 1,779,380 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 37.79 | 1,200 | 45,348 | 1,778,180 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 37.79 | 1,200 | 45,348 | 1,778,180 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 20,668 | 6,820 | 328,080 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 20,668 | 6,820 | 328,080 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 311,400 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 311,400 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 294,720 |
| Jul 31 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 294,720 |
| Jun 23 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 33,132 | 10,934 | 1,811,312 |
| Jun 23 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 45.65 | 19,629 | 896,064 | 1,791,683 |
| Jun 23 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 46.15 | 13,503 | 623,163 | 1,778,180 |
| Jun 23 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 33,132 | 10,934 | 348,748 |
| Jun 23 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 33,132 | 10,934 | 1,811,312 |
| Jun 23 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 45.65 | 19,629 | 896,064 | 1,791,683 |
| Jun 23 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 46.15 | 13,503 | 623,163 | 1,778,180 |
| Jun 23 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 33,132 | 10,934 | 348,748 |
| Jun 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 28,440 | 9,385 | 1,806,620 |
| Jun 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 43.76 | 400 | 17,504 | 1,806,220 |
| Jun 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 44.38 | 28,040 | 1,244,415 | 1,778,180 |
| Jun 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 16,680 | 5,504 | 1,794,860 |
| Jun 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 44.41 | 16,680 | 740,759 | 1,778,180 |
| Jun 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 24,560 | 8,105 | 1,802,740 |
| Jun 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 44.91 | 24,160 | 1,085,026 | 1,778,580 |
| Jun 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 45.52 | 400 | 18,208 | 1,778,180 |
| Jun 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 28,440 | 9,385 | 423,120 |
| Jun 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 16,680 | 5,504 | 406,440 |
| Jun 19 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 24,560 | 8,105 | 381,880 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 50,000 | 16,500 | 1,928,180 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 39.31 | 900 | 35,379 | 1,927,280 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 39.95 | 49,100 | 1,961,545 | 1,878,180 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 50,000 | 16,500 | 1,928,180 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 40.46 | 50,000 | 2,023,000 | 1,878,180 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 50,000 | 16,500 | 1,928,180 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 40.29 | 50,000 | 2,014,500 | 1,878,180 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 0.00 | 100,000 | 0 | 1,778,180 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 50,000 | 16,500 | 551,560 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 50,000 | 16,500 | 501,560 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 50,000 | 16,500 | 451,560 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 50,000 | 16,500 | 1,928,180 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 39.31 | 900 | 35,379 | 1,927,280 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 39.95 | 49,100 | 1,961,545 | 1,878,180 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 50,000 | 16,500 | 1,928,180 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 40.46 | 50,000 | 2,023,000 | 1,878,180 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 50,000 | 16,500 | 1,928,180 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 40.29 | 50,000 | 2,014,500 | 1,878,180 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 0.00 | 100,000 | 0 | 1,778,180 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 50,000 | 16,500 | 551,560 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 50,000 | 16,500 | 501,560 |
| May 21 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 50,000 | 16,500 | 451,560 |
| May 08 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 45,000 | 14,850 | 1,923,180 |
| May 08 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 35.47 | 36,186 | 1,283,517 | 1,886,994 |
| May 08 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 36.13 | 8,814 | 318,450 | 1,878,180 |
| May 08 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 45,000 | 14,850 | 601,560 |
| Apr 15 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 5,560 | 1,835 | 1,883,740 |
| Apr 15 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 24.83 | 1,500 | 37,245 | 1,882,240 |
| Apr 15 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 25.62 | 900 | 23,058 | 1,881,340 |
| Apr 15 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 26.74 | 3,160 | 84,498 | 1,878,180 |
| Apr 15 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 33,360 | 11,009 | 1,911,540 |
| Apr 15 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 28.20 | 33,360 | 940,752 | 1,878,180 |
| Apr 15 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 11,120 | 3,670 | 1,889,300 |
| Apr 15 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 27.62 | 500 | 13,810 | 1,888,800 |
| Apr 15 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 28.34 | 10,620 | 300,971 | 1,878,180 |
| Apr 15 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 5,560 | 1,835 | 691,040 |
| Apr 15 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 33,360 | 11,009 | 657,680 |
| Apr 15 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 11,120 | 3,670 | 646,560 |
| Mar 23 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 11,120 | 3,670 | 1,889,300 |
| Mar 23 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 22.30 | 11,120 | 247,976 | 1,878,180 |
| Mar 23 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 5,560 | 1,835 | 1,883,740 |
| Mar 23 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 22.37 | 3,700 | 82,769 | 1,880,040 |
| Mar 23 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 23.50 | 973 | 22,866 | 1,879,067 |
| Mar 23 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 24.38 | 887 | 21,625 | 1,878,180 |
| Mar 23 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 11,120 | 3,670 | 702,160 |
| Mar 23 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 5,560 | 1,835 | 696,600 |
| Feb 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 11,120 | 3,670 | 1,889,300 |
| Feb 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 31.56 | 11,120 | 350,947 | 1,878,180 |
| Feb 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 11,120 | 3,670 | 713,280 |
| Feb 18 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 31.71 | 300,000 | 9,513,000 | 300,000 |
| Feb 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 11,120 | 3,670 | 1,889,300 |
| Feb 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 31.18 | 11,120 | 346,722 | 1,878,180 |
| Feb 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Buy | 0.33 | 11,120 | 3,670 | 1,889,300 |
| Feb 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Sell | 31.30 | 11,120 | 348,056 | 1,878,180 |
| Feb 12 2020 | ADPT | Adaptive Biotechnologies ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | 0.33 | 11,120 | 3,670 | 735,200 |